Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q3 2019 Earnings

6AugConfirmed

Q4 2018

Q1 2019

Q2 2019

Q3 2019

-0.23

-0.15

-0.07

0.01

Details

Expected EPS

-0.15

Actual EPS

-0.1

Surprise EPS

0.05

Surprise Percent

+33.33%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.1 per share for Q3 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.